Clinical trial

Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data

NCT04354376

Study summary

ClinicalTrials.gov

Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Loop diuretics, thiazides, dihydropyridines Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Telmisartan Normalized identity: telmisartan View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-09-22

PhaseN/A

Conditions

Hypertensionunresolved

Interventions

Loop diuretics, thiazides, dihydropyridinesDRUG

TelmisartanDRUG · verified · RxNorm: telmisartan

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04354376 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.